Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008:3–30. doi: 10.1007/978-0-387-75722-3_1

Influenza: Biology, Infection, and Control

Bryan Roberts 3
Editors: Yichen Lu1, M Essex1, Bryan Roberts2
PMCID: PMC7120528

Abstract

The growth of the human population has profoundly affected the global ecosystem, influencing the animal population balance, the availability of fresh water, arable land, biotic production, and atmospheric gases. The human ecological impact has significantly accelerated the evolutionary change of numerous organisms. For example, the production of human medicine and food has resulted in the rapid evolution of drug-resistant pathogenic organisms as well as plants and insects resistant to pesticides (Palumbi, 2001). Recently, the nutritional support of the human population has relied on the vast monoculture of domestic mammals and birds, which has facilitated the emergence of pathogenic enzootic organisms that infect both animals and humans. This chapter will focus on the global threat to human health represented by the highly contagious enzootic virus influenza. It will also discuss current efforts and future improvements to protect humans from global influenza epidemics and pandemics.

Keywords: Influenza Virus, Avian Influenza, Influenza Vaccine, H5N1 Virus, Avian Influenza Virus

Contributor Information

Yichen Lu, Email: yichenlu@hsph.harvard.edu.

M. Essex, Email: messex@hsph.harvard.edu

Bryan Roberts, Email: bryanr1@comcast.net.

Bryan Roberts, Email: bryanr1@comcast.net.

References

  1. Almond JW. A single gene determines the host range of influenza. Nature. 1977;270:617–618. doi: 10.1038/270617a0. [DOI] [PubMed] [Google Scholar]
  2. Alexander DJ. A Review of avian influenza in different bird species. Veterinary Microbiology. 2000;74:3–13. doi: 10.1016/S0378-1135(00)00160-7. [DOI] [PubMed] [Google Scholar]
  3. Baigent SJ, McCauley JW. Influenza type A in humans, mammals and birds: Determinants of virus host-range and interspecies transmission. BioEssays. 2003;25:657–671. doi: 10.1002/bies.10303. [DOI] [PubMed] [Google Scholar]
  4. Banks J, Speidel EC, McCauley JW, Alexander DJ. Phylogenetic analysis of H7 hemagglutinin subtype influenza A viruses. Archives of Virology. 2000;145:1047–1058. doi: 10.1007/s007050050695. [DOI] [PubMed] [Google Scholar]
  5. Banks J, Speidel EC, Moore E, Plowright L, Piccirillo A, Capua I, Cordioli P, Fioretti A, Alexander DJ. Changes in the hemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Archives of Virology. 2001;146:963–973. doi: 10.1007/s007050170128. [DOI] [PubMed] [Google Scholar]
  6. Barry JM. The Great Influenza. Harmondsworth: Penguin; 2004. [Google Scholar]
  7. Barry DW, Mayner RE, Meisler JM, Seligmann EB., Jr. Evaluation and control of vaccines for the National Influenza Immunization Program. Journal of Infectious Diseases. 1977;136:S407–S414. doi: 10.1093/infdis/136.supplement_3.s407. [DOI] [PubMed] [Google Scholar]
  8. Bean WJ, Webster RG. Phenotypic properties associated with influenza genome segments. In: Mahy BWJ, Barry RD, editors. Negative Strand Viruses and the Host Cell. London: Academic; 1978. pp. 685–692. [Google Scholar]
  9. Black RA, Rota PA, Gorodkova N, Klenk HD, Kendal AP. Antibody response of the M2 protein of influenza A virus expressed in insect cells. Journal of General Virology. 1993;74:143–146. doi: 10.1099/0022-1317-74-1-143. [DOI] [PubMed] [Google Scholar]
  10. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamatane resistance among Influenza A viruses isolated early during the 2005–2006 influenza season in the United States. JAMA. 2006;295(8):891–894. doi: 10.1001/jama.295.8.joc60020. [DOI] [PubMed] [Google Scholar]
  11. Brown, F., Robertson, J. S., Schild, G. C., & Wood, J. M. (1999). Inactivated influenza vaccines prepared in cell culture. Developments in Biological Standardization, 98 [PubMed]
  12. Brugha R, Sterling M, Walt G. GAVI, the first steps: Lessons for the Global Fund. Lancet. 2002;359:435–438. doi: 10.1016/S0140-6736(02)07607-9. [DOI] [PubMed] [Google Scholar]
  13. Capua I, Alexander DJ. Avian influenza: Recent developments. Avian Pathology. 2004;33:393–404. doi: 10.1080/03079450410001724085. [DOI] [PubMed] [Google Scholar]
  14. Capua I, Marangon S. The avian influenza epidemic in Italy, 1999–2000: a review. Avian Pathology. 2000;29:289–294. doi: 10.1080/03079450050118403. [DOI] [PubMed] [Google Scholar]
  15. Chen H, Smith GJD, Zhang SY, Qin K, Wang J, Li KS, Webster RG, Peiris JSM, Guan Y. H5N1 virus outbreak in migratory waterfowl. Nature. 2005;436:191–192. doi: 10.1038/nature03974. [DOI] [PubMed] [Google Scholar]
  16. Cleaveland S, Laurenson MK, Taylor LH. Diseases of humans and their domestic mammals: Pathogen characteristics, host range and the risk of emergence. Philosophical Transactions of the Royal Society of London. 2001;356:991–999. doi: 10.1098/rstb.2001.0889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian and equine H2 and H3 influenza isolates. Virology. 1994;205:17–23. doi: 10.1006/viro.1994.1615. [DOI] [PubMed] [Google Scholar]
  18. Cox NJ, Subbarao K. Global epidemiology of influenza: Past and present. Annual Reviews of Medicine. 2000;51:407–421. doi: 10.1146/annurev.med.51.1.407. [DOI] [PubMed] [Google Scholar]
  19. Daly JM, Newton JR, Mumford JA. Current perspectives on control of equine influenza. Veterinary Research. 2004;35:411–423. doi: 10.1051/vetres:2004023. [DOI] [PubMed] [Google Scholar]
  20. Epstein SL, Tumpey TM, Misplon JA, Lo C-Y, Cooper LA, Subbarao K, Renshaw M, Sambhara S, Katz JM. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerging Infectious Diseases. 2002;8:796–801. doi: 10.3201/eid0808.010476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu T-M, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, Condra JH, Davies M-E, Liao J, Emini EA, Shiver JW. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets and rhesus monkeys. Vaccine. 2004;22:2993–3003. doi: 10.1016/j.vaccine.2004.02.021. [DOI] [PubMed] [Google Scholar]
  22. Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437:209–214. doi: 10.1038/nature04017. [DOI] [PubMed] [Google Scholar]
  23. Fiers W, De Filette M, Birkett A, Nierynck S, Min Jou W. A universal influenza A vaccine. Virus Research. 2004;103:173–176. doi: 10.1016/j.virusres.2004.02.030. [DOI] [PubMed] [Google Scholar]
  24. Fouchier RAM, Osterhaus ADME, Brown IH. Animal influenza virus surveillance. Vaccine. 2003;21:1754–1757. doi: 10.1016/S0264-410X(03)00067-7. [DOI] [PubMed] [Google Scholar]
  25. Francis T, Jr., Salk JE, Quilligan JJJ. Experience with vaccination against influenza in the spring of 1947. American Journal of Public Health. 1947;37:1013–1016. doi: 10.2105/AJPH.37.8.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gambaryan AS, Piskarev VE, Yamskov IA, Sakharov AM, Tuzikov AB, Bovin NV, Nifant’ev NE, Matrosovich MN. Human influenza virus recognition of oligosaccharides. FEBS Letters. 1995;366:57–60. doi: 10.1016/0014-5793(95)00488-U. [DOI] [PubMed] [Google Scholar]
  27. Garcia M, Crawford JM, Latimer JW, RiveraCruz E, Perdue ML. Heterogeneity in the hemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza strains in Mexico. Journal of General Virology. 1996;77:1493–1504. doi: 10.1099/0022-1317-77-7-1493. [DOI] [PubMed] [Google Scholar]
  28. Garrett L. The Coming Plague: Newly Emerging Diseases in a World Out of Balance. New York: Farrar, Strauss and Giroux; 1994. [Google Scholar]
  29. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, Dernovoy D, Tatusova T, Bao Y, St George K, Taylor JU, Lipman DJ, Fraser CM, Taubenberger JK, Salzberg SL. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature. 2005;437:1162–1166. doi: 10.1038/nature04239. [DOI] [PubMed] [Google Scholar]
  30. Glezen WP. Emerging Infections: Pandemic Influenza. Epidemiologic Reviews. 1996;18(1):64–76. doi: 10.1093/oxfordjournals.epirev.a017917. [DOI] [PubMed] [Google Scholar]
  31. Harvey R, Martin ACR, Zambon M, Barclay WS. Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. Journal of Virology. 2004;78:502–507. doi: 10.1128/JVI.78.1.502-507.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. Journal of Infectious Diseases. 2005;192:1311–1314. doi: 10.1086/444399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Helenius A. Unpacking the incoming influenza virus. Cell. 1992;69:577–578. doi: 10.1016/0092-8674(92)90219-3. [DOI] [PubMed] [Google Scholar]
  34. Hilleman MR. Personal historical chronicle of six decades of basic and applied research in virology, immunology and vaccinology. Immunological Reviews. 1999;170:7–27. doi: 10.1111/j.1600-065X.1999.tb01325.x. [DOI] [PubMed] [Google Scholar]
  35. Hinshaw VS, Webster RG, Turner B. The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Journal of Microbiology. 1980;26:622–629. doi: 10.1139/m80-108. [DOI] [PubMed] [Google Scholar]
  36. Horimoto T, Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clinical Microbiology Reviews. 2001;14:129–149. doi: 10.1128/CMR.14.1.129-149.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ionescu RM, Przysiecki CT, Liang X, Garsky VM, Fan J, Wang B, Troutman R, Pippeon Y, Flanagan E, Shiver J, Shi L. Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. Journal of Pharmaceutical Science. 2006;95:70–79. doi: 10.1002/jps.20493. [DOI] [PubMed] [Google Scholar]
  38. Ito T, Gorman OT, Kawaoka Y, Bean WJ, Webster RG. Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. Journal of Virology. 1991;65:5491–5498. doi: 10.1128/jvi.65.10.5491-5498.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Karasin AI, Olsen CW, Anderson GA. Genetic characterization of an H1N2 influenza isolated from a pig in Indiana. Journal of Clinical Microbiology. 2000;38:2453–2456. doi: 10.1128/jcm.38.6.2453-2456.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kawaoka Y, Krauss S, Webster RG. Avian to human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. Journal of Virology. 1989;63:4603–4608. doi: 10.1128/jvi.63.11.4603-4608.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Koen JS. A practical method for field diagnosis of swine diseases. American Journal of Veterinary Medicine. 1919;14:468–470. [Google Scholar]
  42. Lamb RA, Zebedee SL, Richardson CD. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 1985;40:627–633. doi: 10.1016/0092-8674(85)90211-9. [DOI] [PubMed] [Google Scholar]
  43. Le QM, Kiso M, Someya K, Sakai Y, Nguyen T, H, Nguyen KHL, Dinh Pham N, Nguyen HN, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y. Isolation of drug resistant H5N1 virus. Nature. 2005;437:1108. doi: 10.1038/4371108a. [DOI] [PubMed] [Google Scholar]
  44. Levi R, Arnon R. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross strain protection. Vaccine. 1996;14:85–92. doi: 10.1016/0264-410X(95)00088-I. [DOI] [PubMed] [Google Scholar]
  45. Liu W, Peng Z, Liu Z, Lu Y, Ding J, Chen Y-H. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine. 2004;23:366–371. doi: 10.1016/j.vaccine.2004.05.028. [DOI] [PubMed] [Google Scholar]
  46. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME. Containing pandemic influenza at the source. Science. 2005;309:1083–1087. doi: 10.1126/science.1115717. [DOI] [PubMed] [Google Scholar]
  47. Luk J, Gross P, Thompson WW. Observations on mortality during the 1918 influenza pandemic. Clinical Infectious Diseases. 2001;33:1375–1378. doi: 10.1086/322662. [DOI] [PubMed] [Google Scholar]
  48. Maassab HF, Bryant ML. The development of live attenuated cold adapted influenza virus vaccine for humans. Reviews in Medical Virology. 1999;9:237–244. doi: 10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  49. Matrosovitch M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y. Early alterations of the receptor-binding properties of H1, H2 and H3 avian influenza virus hemagglutinins after their introduction into mammals. Journal of Virology. 2000;74:8502–8512. doi: 10.1128/JVI.74.18.8502-8512.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. McMichael AJ. Environmental and social influences on emerging infectious diseases: Past, present and future. Philosophical Transactions of the Royal Society of London. 2004;359:1049–1058. doi: 10.1098/rstb.2004.1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Mozdzanowska K, Feng JQ, Eid M, Kragol G, Cudic M, Otvos L, Gerhard W. Induction of Influenza type A virus specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine. 2003;21:2616–2626. doi: 10.1016/S0264-410X(03)00040-9. [DOI] [PubMed] [Google Scholar]
  52. Murphy FA. Virology. In: Fields BN, Knipe DM, Howley PM, editors. Virus taxonomy. Philadelphia: Lippincott-Raven; 1996. pp. 15–57. [Google Scholar]
  53. Murray R. Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1868–69. Bulletin of the World Health Organization. 1969;41:495–496. [PMC free article] [PubMed] [Google Scholar]
  54. Naeem K. Proceedings of the International Symposium on Avian Influenza American Association of Avian Pathologists. Georgia, USA: Pennsylvania, Athens; 1998. The avian influenza outbreak in South Central Asia; pp. 31–35. [Google Scholar]
  55. Nierynck S, Deroo T, Saelens X, Vanlandschoot P, Min Lou W, Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nature Medicine. 1999;5:1157–1163. doi: 10.1038/13484. [DOI] [PubMed] [Google Scholar]
  56. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): A single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology. 2000;278:587–596. doi: 10.1006/viro.2000.0679. [DOI] [PubMed] [Google Scholar]
  57. Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Xu X, Wang J, Ma J, Fan Y, Rakestraw KM, Webster RG, Hoffman E, Krauss S, Zheng J, Zhang Z, Naeve CW. Large-scale sequence analysis of avian influenza isolates. Science. 2006;311:1576–1580. doi: 10.1126/science.1121586. [DOI] [PubMed] [Google Scholar]
  58. Oxford JS, McGeoch DJ, Schild GC, Beare AS. Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature. 1978;273:778–779. doi: 10.1038/273778a0. [DOI] [PubMed] [Google Scholar]
  59. PAHO Meeting. (2005). Avian Influenza and Pandemic Preparedness: The Vaccine Industry Perspective. Washington, DC, 21 November 2005
  60. Palumbi SR. Humans as the world’s greatest evolutionary force. Science. 2001;293(5536):1786–1790. doi: 10.1126/science.293.5536.1786. [DOI] [PubMed] [Google Scholar]
  61. Payne AM. The influenza programme of WHO. Bulletin of the World Health Organization. 1953;8:755–774. [PMC free article] [PubMed] [Google Scholar]
  62. Perdue M, Crawford J, Garcia M, Latimer J, Swayne D. Occurrence and possible mechanisms of cleavage site insertions in the avian influenza hemagglutinin gene. In Proceedings of the 4th International Symposium on Avian Influenza. Georgia, USA: Athens; 1998. pp. 182–193. [Google Scholar]
  63. Perroncito E. Epizoozia tifoide nei gallinacei. Annals of the Academy of Agriculture. 1878;21:87–93. [Google Scholar]
  64. Petersen LR, Roehrig JT. West Nile Virus: A reemerging global pathogen. Emerging Infectious Disease. 2001;7(4):611–614. doi: 10.3201/eid0704.010401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Potter CW. A history of influenza. Journal of Applied Microbiology. 2001;91:572–579. doi: 10.1046/j.1365-2672.2001.01492.x. [DOI] [PubMed] [Google Scholar]
  66. Puzelli S, Di Trani L, Fabiani C, Campitelli L, De Marco MA, Capua I, Aguilera JF, Zambom M, Donatelli I. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. Journal of Infectious Diseases. 2005;192:1318–1322. doi: 10.1086/444390. [DOI] [PubMed] [Google Scholar]
  67. Rappuoli R, Miller HI, Falkow S. The intangible value of vaccines. Science. 2002;297:937–939. doi: 10.1126/science.1075173. [DOI] [PubMed] [Google Scholar]
  68. Reid AH, Fanning TG, Janczewski TA, Lourens RM, Tanbenberger JK. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology. 2004;78:12462–12470. doi: 10.1128/JVI.78.22.12462-12470.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Roberts BE, Lu Y. In: Infectious Diseases in Asia: Implications for Global Health in Aids in Asia. Lu Y, Essex M, editors. New York: Kluwer/Plenum; 2004. [Google Scholar]
  70. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC. Single amino acid substitutions in influenza haemagglutinin change receptor specificity. Nature. 1983;304:76–78. doi: 10.1038/304076a0. [DOI] [PubMed] [Google Scholar]
  71. Rohm C, Horimoto T, Kawaoka Y, Suss J, Webster RG. Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology. 1995;209:664–670. doi: 10.1006/viro.1995.1301. [DOI] [PubMed] [Google Scholar]
  72. Rojas H, Moreira R, Avalos P, Marangon S. Avian influenza in poultry in Chile. Veterinary Record. 2002;151:188. [PubMed] [Google Scholar]
  73. Scholtissek C, Murphy BR. Host range mutants of an influenza A virus. Archives of Virology. 1978;58:323–333. doi: 10.1007/BF01317824. [DOI] [PubMed] [Google Scholar]
  74. Shaw MW, Xu X, Normand S, Ueki RT, Kumimoto GY, Hall H, Kimov A, Cox NJ, Subbarao K. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000–2001 and 2001–2002 seasons. Virology. 2002;303:1–8. doi: 10.1006/viro.2002.1719. [DOI] [PubMed] [Google Scholar]
  75. Shinya K, Ebinall M, Shinya Y, Ono M, Kasai N, Kawaoka Y. Influenza virus receptors in the human airway. Nature. 2006;440:435–436. doi: 10.1038/440435a. [DOI] [PubMed] [Google Scholar]
  76. Shope RE. Swine influenza filtration experiments and etiology. Journal of Experimental Medicine. 1931;54:373–385. doi: 10.1084/jem.54.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: Introducing a severity index. American Journal of Public Health. 1997;87:1944–1950. doi: 10.2105/AJPH.87.12.1944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. Journal of Infectious Diseases. 1998;178:53–60. doi: 10.1086/515616. [DOI] [PubMed] [Google Scholar]
  79. Slepushkin VA, Katz JM, Black RA, Gamble WA, Rota PA, Cox NJ. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine. 1995;13(15):1399–1402. doi: 10.1016/0264-410X(95)92777-Y. [DOI] [PubMed] [Google Scholar]
  80. Smith W, Andrews CH, Laidlaw PP. A virus obtained from influenza patients. Lancet. 1933;2:66–68. doi: 10.1016/S0140-6736(00)78541-2. [DOI] [Google Scholar]
  81. Steinhauer DA. Minireview role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology. 1999;258:1–20. doi: 10.1006/viro.1999.9716. [DOI] [PubMed] [Google Scholar]
  82. Stevens, J., Blixt, O, Tumpey, T. M., Taubenberger, J. K., Paulson, J. C., & Wilson, I. A. (2006). Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Sciencexpress Research article, http://www.sciencexpress.org, 20 March 2006 [DOI] [PubMed]
  83. Sturm-Ramirez KM, Hulse-Post DJ, Govorkova EA, Humberd J, Seiler P, Puthavathana P, Buranathai C, Nguyen TD, Chaisingh A, Long HT, Naipospos TSP, Chen H, Ellis TM, Guan Y, Peiris JSM, Webster RG. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? Journal of Virology. 2005;79:11269–11279. doi: 10.1128/JVI.79.17.11269-11279.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Sugrue RJ, Hay AJ. Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology. 1991;180:617–624. doi: 10.1016/0042-6822(91)90075-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Szucs T. The socio-economic burden of influenza. The Journal of Antimicrobial Chemotherapy. 1999;44:11–15. doi: 10.1093/jac/44.suppl_2.11. [DOI] [PubMed] [Google Scholar]
  86. Tilman D. Global environmental impacts of agricultural expansion: The need for sustainable and efficient practices. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:5995–6000. doi: 10.1073/pnas.96.11.5995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Treanor JJ, Snyder MH, London WT, Murphy BR. The B allele of the NS gene of avian influenza viruses but not the A allele attenuates a human influenza A virus for squirrel monkeys. Virology. 1989;171:1–9. doi: 10.1016/0042-6822(89)90504-7. [DOI] [PubMed] [Google Scholar]
  88. Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. Journal of Virology. 1990;64:1375–1377. doi: 10.1128/jvi.64.3.1375-1377.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, Nicholls JM, Chokephaibulkit K, Vanprapar N, Auewarakul P. Influenza A H5N1 replication sites in humans. Emerging Infectious Diseases. 2005;11:1036–1041. doi: 10.3201/eid1107.041313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. United Nations . World Population Prospects: The 2004 Revision. New York: United Nations; 2004. [Google Scholar]
  91. Van Riel, D., Munster, V. J. deWit, E. Rimmelzwaan, G. F., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Kuiken, T. (2006). H5N1 virus attachment to lower respiratory tract. Sciencexpress Brevia, http://www.sciencexpress.org, 23 March 2006 [DOI] [PubMed]
  92. Vijayanand P, Wilkins E, Woodhead M. Severe acute respiratory syndrome (SARS): A review. Clinical Medicine. 2004;4:152–160. doi: 10.1007/s10238-004-0050-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Villarreal CL, Flores AO. Proceedings of the International Symposium on Avian Influenza American Association of Avian Pathologists, Pennsylvania. Georgia, USA: Athens; 1997. The Mexican avian influenza H5N2 outbreak; pp. 18–22. [Google Scholar]
  94. Webby RJ, Swenson SL, Krauss SL, Gerrish PJ, Goyal SM, Webster RG. Evolution of swine H3N2 influenza viruses in the United States. Journal of Virology. 2000;74:8243–8251. doi: 10.1128/JVI.74.18.8243-8251.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Webster RG, Kawaoka Y. Avian influenza. Critical Reviews in Poultry Biology. 1988;1:211–246. [Google Scholar]
  96. Webster RG, Laver WG. The origin of pandemic influenza. Bulletin of the World Health Organization. 1972;47:449–452. [PMC free article] [PubMed] [Google Scholar]
  97. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiological Reviews. 1992;56:152–179. doi: 10.1128/mr.56.1.152-179.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine. 2004;10(12):S70–S76. doi: 10.1038/nm1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Wood JM. Developing vaccines against pandemic influenza. Philosophical Transactions of the Royal Society of London. 2001;356:1953–1960. doi: 10.1098/rstb.2000.0741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. World Health Organization . Influenza Pandemic Preparedness Plan. The Role of WHO and Guidelines for National and Regional Planning. Geneva: WHO; 1999. [Google Scholar]
  101. World Health Organization . Influenza Fact Sheet #211. Geneva: WHO; 2003. [Google Scholar]
  102. Writing Committee of the World Health Organization Consultation on Human Influenza A/H5 Avian influenza A (H5N1) infections in humans. New England Journal of Medicine. 2005;353:1374–1385. doi: 10.1056/NEJMra052211. [DOI] [PubMed] [Google Scholar]
  103. Zebedee SL, Lamb RA. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. Journal of Virology. 1988;62:2762–2772. doi: 10.1128/jvi.62.8.2762-2772.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infections in Asia are provided here courtesy of Nature Publishing Group

RESOURCES